Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Authors not listed

Genentech, Inc. · 2027

Abstract

This study will assess the safety and efficacy of RO7965032 to address a significant unmet medical need in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2027). A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration. <em>Genentech, Inc.</em>. https://clinicaltrials.gov/study/NCT07851259
Vancouver
Anonymous. A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration. Genentech, Inc.. 2027.
BibTeX
@misc{anon2027APhase, title = {A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration}, author = {Anonymous}, journal = {Genentech, Inc.}, year = {2027}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings